Proteomics: a major new technology for the drug discovery process.

Proteomics: a major new technology for the drug discovery process.

Proteomics is a new enabling technology that is being integrated into the drug discovery process. This will facilitate the systematic analysis of proteins across any biological system or disease, forwarding new targets and information on mode of action, toxicology and surrogate markers. Proteomics i...

Полное описание

Библиографические подробности
Главные авторы:	Page, M, Amess, B, Rohlff, C, Stubberfield, C, Parekh, R
Формат:	Journal article
Язык:	English
Опубликовано:	1999

Схожие документы

Applying genomic and proteomic microarray technology in drug discovery /
по: 224468 Matson, Robert S.
Опубликовано: (c201)

Applying genomic and proteomic microarray technology in drug discovery /
по: 224468 Matson, Robert S.
Опубликовано: (2004)

Tissue proteomics : pathways, biomarkers, and drug discovery /
по: Liu, Brian C.-S., и др.
Опубликовано: (2008)

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.
по: Page, M, и др.
Опубликовано: (1999)

Comparative genomics and proteomics in drug discovery /
по: Parrington, John, и др.
Опубликовано: (2006)

Bioinformatics methods and applications : genomics, proteomics and drug discovery /
по: 384476 Rastogi, S. C., и др.
Опубликовано: (c200)

Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism.
по: Gagneux, P, и др.
Опубликовано: (2001)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
по: Hyebin Choi, и др.
Опубликовано: (2021-03-01)

Chemical Proteomics Applied to Target Identification and Drug Discovery
по: Steven H.L. Verhelst, и др.
Опубликовано: (2005-02-01)

Aptamer-based multiplexed proteomic technology for biomarker discovery.
по: Larry Gold, и др.
Опубликовано: (2010-12-01)

The Drug Discovery and Development Process in the New Millennium
по: Michael D Levy
Опубликовано: (2000-01-01)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
по: Thomas J. Hedl, и др.
Опубликовано: (2019-06-01)

Process optimization in drug discovery
по: Roberts, Rebecca Anne, M.B.A. Massachusetts Institute of Technology
Опубликовано: (2007)

Proteomics for biological discovery /
по: 183962 Veenstra, Timothy D., и др.
Опубликовано: (2006)

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
по: Mingjie Zou, и др.
Опубликовано: (2024-07-01)

Editorial: Mass spectrometry-based proteomics in drug discovery and development
по: Martin Pejchinovski, и др.
Опубликовано: (2024-07-01)

Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery
по: Crhisllane Rafaele dos Santos Vasconcelos, и др.
Опубликовано: (2021-04-01)

Drug Discovery Process
по: Kenichi KUWASHIMA
Опубликовано: (2016-05-01)

Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
по: Nadia Martinez-Martin
Опубликовано: (2017-01-01)

Knowledge discovery in proteomics /
по: 193240 Jurisica, Igor, и др.
Опубликовано: (2006)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
по: Gangadharan, B, и др.
Опубликовано: (2011)

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
по: Hélène Lê, и др.
Опубликовано: (2024-04-01)

Production of Proteins of the SARS-CoV‑2 Proteome for Drug Discovery
по: Choon Kim, и др.
Опубликовано: (2021-07-01)

Cysteine-specific Chemical Proteomics: From Target Identification to Drug Discovery
по: Dominic G. Hoch, и др.
Опубликовано: (2016-11-01)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
по: Wei Liu, и др.
Опубликовано: (2022-03-01)

Proteome discovery pipeline for mass spectrometry-based proteomics
по: Buck Charles R, и др.
Опубликовано: (2008-07-01)

The Major Role of Clinicians in the Discovery of Off-Label Drug Therapies
по: DeMonaco, Harold J., и др.
Опубликовано: (2005)

Acanthocheilonema viteae: phosphorylcholine is attached to the major excretory-secretory product via an N-linked glycan.
по: Harnett, W, и др.
Опубликовано: (1993)

Drug discovery and development: technology in transition
по: Hill, RG, и др.
Опубликовано: (2021)

Drug discovery and development : technology in transition /
по: Rang, H. P.
Опубликовано: (2006)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
по: Xiaonan Liu, и др.
Опубликовано: (2021-10-01)

Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics
по: Petra Hudler, и др.
Опубликовано: (2014-01-01)

Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics
по: Andrew M. Piggott, и др.
Опубликовано: (2005-06-01)

Proteomics for cancer biomarker discovery
по: Volchenboum, Samuel Louis
Опубликовано: (2008)

Proteomics Discovery of Disease Biomarkers
по: Mamoun Ahram, и др.
Опубликовано: (2008-01-01)

Proteomics Discovery of Disease Biomarkers
по: Mamoun Ahram, и др.
Опубликовано: (2008-01-01)

New drug discovery and development /
по: Lednicer, Daniel, 1929-
Опубликовано: (2007)

New drug discovery: Where are we heading to?
по: M R Yadav
Опубликовано: (2013-01-01)

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
по: Fischer, R, и др.
Опубликовано: (2012)

Epigenetic protein families: a new frontier for drug discovery.
по: Arrowsmith, C, и др.
Опубликовано: (2012)